Freedom Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,129
Closed -$873K 235
2025
Q2
$873K Buy
8,129
+2,751
+51% +$278K 0.07% 287
2025
Q1
$543K Sell
5,378
-691
-11% -$69.6K 0.05% 402
2024
Q4
$542K Sell
6,069
-341
-5% -$30K 0.05% 408
2024
Q3
$537K Sell
6,410
-18
-0.3% -$1.42K 0.04% 420
2024
Q2
$495K Buy
6,428
+2,404
+60% +$176K 0.04% 425
2024
Q1
$276K Buy
+4,024
New +$259K 0.02% 639
2023
Q3
Sell
-4,005
Closed -$217K 688
2023
Q2
$217K Buy
+4,005
New +$209K 0.02% 637
2019
Q3
Sell
-7,873
Closed -$338K 694
2019
Q2
$338K Buy
+7,873
New +$303K 0.03% 481

Other funds holding BSX

Freedom Investment Management's BSX Position: Q3 2025 in Review

Freedom Investment Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 8,129 shares — an estimated $873K sold.

Freedom Investment Management first reported a position in BSX in Q2 2019 and held it in 8 quarters. The position peaked at $873K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Freedom Investment Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 8,129 Boston Scientific shares in Q3 2025, an estimated $873K.
  • Freedom Investment Management first reported a position in Boston Scientific in Q2 2019 and held it in 8 quarters.
  • Freedom Investment Management's Boston Scientific position peaked at $873K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.